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Background and aim: The trend in reported case counts 
of invasive  Listeria monocytogenes  (Lm), a poten-
tially severe food-borne disease, has been increas-
ing since 2008. In 2015, 2,224 cases were reported 
in the European Union/European Economic Area (EU/
EEA). We aimed to validate the microbiological and 
epidemiological aspects of an envisaged EU/EEA-
wide surveillance system enhanced by routine whole 
genome sequencing (WGS).  Methods:  WGS and core 
genome multilocus sequence typing (cgMLST) were 
performed on isolates from 2,726 cases from 27 EU/
EEA countries from 2010–15. Results: Quality controls 
for contamination, mixed  Lm  cultures and sequence 
quality classified nearly all isolates with a minimum 
average coverage of the genome of 55x as accept-
able for analysis. Assessment of the cgMLST variation 
between six different pipelines revealed slightly less 
variation associated with assembly-based analysis 
compared to reads-based analysis. Epidemiological 
concordance, based on 152 isolates from 19 confirmed 
outbreaks and a cluster cutoff of seven allelic differ-
ences, was good (sensitivity >  95% for two cgMLST 
schemes of 1,748 and 1,701 loci each; PPV 58–68%). 
The proportion of sporadic cases was slightly below 
50%. Of remaining isolates, around one third were in 
clusters involving more than one country, often span-
ning several years. Detection of multi-country clusters 
was on average several months earlier when pooling 
the data at EU/EEA level, compared with first detec-
tion at national level.  Conclusions: These findings 
provide a good basis for comprehensive EU/EEA-wide, 
WGS-enhanced surveillance of listeriosis. Time limits 
should not be used for hypothesis generation during 
outbreak investigations, but should be for analytical 
studies.
Introduction
Invasive infection by Listeria monocytogenes (Lm) leads 
to relatively rare but serious food-borne disease mainly 
affecting elderly people, immunocompromised indi-
viduals and pregnant women. Clinical manifestations 
include sepsis and infection of the central nervous sys-
tem, which can lead to lifelong sequelae or death [1,2]. 
Pregnancy-associated listeriosis can result in preterm 
birth, miscarriage or stillbirth [2,3]. In the European 
Union and European Economic Area (EU/EEA), 2,224 
human cases of invasive listeriosis were reported in 
2015, with an overall case fatality rate of 18.8% [4]. 
Reported numbers of cases of listeriosis suggest that 
the incidence of disease slightly increased over the 
period of 2010–15. The incubation period of listeri-
osis is usually 3 to 21 days, but can be as long as 67 
days, depending on the clinical form of the disease [5]. 
Patients frequently have underlying conditions and/
or are elderly, which limits the collection of exposure 
data in some cases. On epidemiological grounds, most 
cases are considered sporadic and detected outbreaks 
usually involve small numbers of patients, which limits 
statistical power in analytical epidemiological studies. 
As a result, most reported cases of listeriosis are diffi-
cult to link to a specific food product or food business 
operator.
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Lm  is able to form biofilms, grow at refrigeration 
temperature, high salt and nitrite concentrations, and 
can be resistant to disinfectants [6,7]. These properties 
contribute to its ability to persist and multiply in the 
food-processing environment and make it difficult to 
control. In the United States (US), a nationwide subtyp-
ing of Lm using pulsed-field gel electrophoresis (PFGE) 
was introduced in 1998. During the following 6 years, 
there was a more than fivefold increase in the number 
of outbreaks where a common food vehicle could be 
identified [8]. In the subsequent 10 years, the introduc-
tion of detailed food history gathering for all listeriosis 
patients resulted in a further increase in the number of 
solved outbreaks per year, as well as a reduction of the 
number of cases per outbreak [9].
PFGE is, however, time-consuming and difficult to 
standardise. In recent years, it has been demonstrated 
that whole genome sequence (WGS)-based subtyp-
ing can provide substantial additional discrimina-
tion and, consequently, can be of benefit to outbreak 
investigations [9-11]. Within the EU/EEA, listeriosis is 
one of the priority diseases for which supranational 
WGS-enhanced surveillance will be initiated in 2018 
[12]. The work presented here supports the prepara-
tion for this surveillance system through a large-scale, 
retrospective, multi-centre study on  Lm  isolates from 
human cases from EU/EEA countries by covering the 
comparison and validation of analytical pipelines, the 
assessment of the epidemiological concordance of the 
results and the potential impact on public health [13]. 
The analytical pipelines are based on the gene-by-gene 
approach recommended by the PulseNet International 
global consortium [14-17].
Methods
WGS was performed on a total of 2,726 Lm isolates from 
human cases from 27 EU/EEA countries and spanning 
years 2010–15 using Illumina MiSeq (Illumina, Inc., 
San Diego, California, US) 2x150 (n = 295), Illumina 
MiSeq 2x250 (n = 243), Illumina MiSeq 2x300 (n = 98), 
Illumina NextSeq 2x150 (n = 1,585) and Illumina HiSeq 
2x100 (n = 422), as well as IonTorrent PGM (Thermo 
Fisher Scientific, Waltham, Maryland, US) (n = 83) plat-
forms. Ten EU/EEA national public health laboratories 
(n = 1,069 isolates) and a commercial sequencing pro-
vider (n = 1,657 isolates) performed the sequencing.
Trimming and de novo assembly
Trimming was performed on Illumina reads with 
Trimmomatic, before any further analysis. This included 
(i) removal of any adaptor sequences, (ii) removal of 
Figure 1
Sequence data quality control based on core genome coverage (CGC), (A) Impact of decreasing CGC on allelic distance (n = 
2,664), (B) Impact of average coverage, before and after trimming, on passing the CGC quality control, using rarefactiona (n 
= 2,609), Listeria monocytogenes whole genome sequencing study, European Union/European Economic Area, 2010‒2015
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aA sliding window of ± 5x coverage was used, with a minimum number of 10 observations per window.
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leading bases with PHRED <  25 (i.e. <  99.7% base call 
accuracy), (iii) removal of trailing bases with PHRED < 25, 
(iv) clipping of the remainder of the read when a sliding 
window of 20 bases has average PHRED <  25, and (v) 
removal of the entire read if length < 36 bases [18].
De novo assembly was performed with SPAdes and 
Velvet algorithms [19,20]. Spades 3.7.1 was run with 
BayesHammer read error correction and assembling 
mode with automatic determination of coverage cutoff, 
a minimum contig length of 300 nucleotides (nt) and 
with MismatchCorrector on. BWA-mem 0.7.12 was sub-
sequently used to map all reads back to the SPAdes 
assembly, and consensus base calling was performed 
on the resulting alignment as an additional mismatch 
correction [21]. Velvet 1.1.04 was run with an automatic 
determination of the coverage cutoff, a minimum con-
tig length of 300 bases using k-mers ranging from 59 to 
69% of the average read length. The assembly with the 
highest N50 was retained. Bowtie2 was used to map 
all reads to this assembly, and consensus base calling 
was performed on the resulting alignment as mismatch 
correction [22].
Allele calling
Allele calling was performed using two core genome 
multilocus sequence typing (cgMLST) schemes: the 
scheme of Moura et al. [10], as implemented in the 
BioNumerics (Applied Maths, Sint-Martens-Latem, 
Belgium) software (1,748 loci, available from  http://
bigsdb.pasteur.fr/listeria) and the scheme of Ruppitsch 
et al. [23], as implemented in the SeqSphere + (RIDOM, 
Münster, Germany) software (1,701 loci, available 
from  http://www.cgmlst.org/ncs/schema/690488/). 
These schemes are further referred to as Moura CG and 
Ruppitsch CG. Both software applications were run 
with default parameters for allele calling, both based 
on either assemblies (assembly-based) or directly on 
reads (reads-based). In turn, each uses the basic local 
alignment search tool nucleotide (BLASTN) software 
to align assembled genomes to reference alleles: word 
size was 11, gap opening penalty 5 and gap exten-
sion penalty 2 [24]. Mismatch penalty was -3 and -1, 
and match reward 2 and 1 in Bionumerics 7.6.2 and 
SeqSphere +3.4.1, respectively. When more than one 
locus on the assembled genome matches a reference 
allele, such multiple allele calls are recorded, but no 
identifier is assigned. The direct reads-based allele call-
ing in BioNumerics matches k-mers of size 35 from all 
known alleles against those of the reads, and consid-
ers the allele found if all its k-mers are present with the 
same number of occurrences. The SeqSphere + reads-
based allele calling first maps the reads to reference 
genome NC_003210.1 using the BWA-SW software, and 
then produces a consensus sequence [21]. BLAST is 
subsequently used to align this sequence against the 
reference alleles for each locus, keeping only align-
ments that cover >  90% of the reference allele [24]. 
Alignments were verified for presence of start and 
stop codons and for a minimum of 70% (Moura CG) 
or 90% (Ruppitsch CG) nt sequence identity to refer-
ence alleles. For IonTorrent sequences, allele calling 
was only done by mapping reads first to the reference 
alleles and then again to the resulting consensus allele 
sequence, each time removing indels of 1 and 2 nt to 
specifically address this type of sequencing error.
To assess the impact of the different pipelines, i.e. 
combinations of input data (directly reads, SPAdes 
assembly or Velvet assembly) and scheme (Moura 
CG or Ruppitsch CG) on cgMLST analysis, two sub-
sets of isolate pairs were used: pairs with AD ≤  7 and 
pairs with AD ≤  150. These correspond respectively 
to closely related isolates likely to share a common 
Table 2
Independent contribution of source data and scheme to variation in allelic distance between different allele calling methods, 
Listeria monocytogenes whole genome sequencing study, European Union/European Economic Area, 2010‒2015
Method 1 Method 2 Pairs for comparison  
AD ≤ 7 (n) vs AD ≤ 150 (n)
Mean CGC 
 
comparison 
method 1 (%) 
vs 2 (%)
ΔAD
a, subset AD ≤ 7 ΔAD
a, subset 
AD ≤ 150
Mean Rangeb Mean Rangea
SPAdes + Moura CG Velvet + Moura CG 313 vs 24,196 99.5 vs 99.7 - 0.2 - 2 to 0 - 0.8 - 5 to 1
SPAdes + Ruppitsch CG Velvet + Ruppitsch CG 1,229 vs 50,233 99.2 vs 99.4 - 0.3 - 2 to 0 - 0.6 - 4 to 1
SPAdes + Moura CG Reads + Moura CG 2,780 vs 135,365 99.5 vs 99.1 - 1.1 - 5 to 1 - 0.6 - 4 to 3
SPAdes + Ruppitsch CG Reads + Ruppitsch CG 1,237 vs 50,881 99.2 vs 98.9 - 1.2 - 4 to 0 - 1.1 - 5 to 2
Velvet + Moura CG Reads + Moura CG 148 vs 9,040 99.7 vs 99.1 - 0.6 - 2 to 1 - 0.7 - 5 to 5
Velvet + Ruppitsch CG Reads + Ruppitsch CG 1,193 vs 50,381 99.4 vs 98.9 - 0.9 - 4 to 1 - 0.6 - 4 to 2
SPAdes + Moura CG SPAdes + Ruppitsch CG 5,255 vs 230,478 99.5 vs 99.2 0.6 - 5 to 3 - 1.9 - 14 to 9
Velvet + Moura CG Velvet + Ruppitsch CG 337 vs 24,196 99.7 vs 99.4 - 0.0 - 4 to 4 - 1.5 - 12 to 8
Reads + Moura CG Reads + Ruppitsch CG 549 vs 19,721 99.1 vs 98.9 0.2 - 3 to 4 - 0.8 - 13 to 10
AD: allelic distance; CG: core genome; CGC: core genome coverage.
aΔAD is calculated as AD of method 1 minus that of method 2
bRange represents the smallest possible ΔAD range for ≥ 95% of the isolate pairs.
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Figure 2
Concordance between cgMLST and epidemiological results for (A) Epidemiologically linked vs unknown or not 
epidemiologically linked pairs of isolatesa, (B) Positive predictive value and sensitivity of single-linkage clustering on 
confirmed outbreaks, (C) Rarefaction curves for sporadic cases, single-country clusters and multi-country clustersb, (D) 
Aggregated time span and evolution of clustersc; Listeria monocytogenes whole genome sequencing study European Union/
European Economic Area, 2010‒2015 (n = 2,664)
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aThe inset shows all pairs up to AD ≤ 150.
bCutoff AD ≤ 7.
cAggregated by setting the first isolate of each cluster at t = 0 and using bins of 26 weeks, i.e. half a year.
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epidemiological link, and to sublineages where iso-
lates are still likely to have common phenotypic prop-
erties that may be relevant, e.g. for source attribution 
[10,25].
Quality control
Numeric quality indicators were defined to assess 
the following quality issues: contamination, Lm mixed 
cultures and sequence read quality. Two thresholds 
were determined per indicator to classify the result 
of the quality control (QC) as (i) acceptable ‘PASS’ or 
acceptable with a warning ‘WARN’ and (ii) not accept-
able ‘FAIL’. The intermediate WARN level was added 
for practical application in public health, where a 
sequence may still be included if the time to re-
sequence is too long compared with the time frame 
within which action should be taken. A final classifica-
tion combining the results from all these quality con-
trols is then made: ‘Accepted’ isolates have all QCs 
PASS, ‘AcceptedForOutbreak’ have some QCs WARN 
but none FAIL and ‘Rejected’ have at least one QC FAIL.
Contamination checks were performed using BLASTN 
by aligning the assembled genomes against fully closed 
genomes of other  Listeria  species (L. ivanovii,  L. mar-
thii, L. seeligeri  and  L. welshimeri) and species often 
encountered in laboratories for enteric diseases, includ-
ing Bacillus cereus, Campylobacter coli, C. fetus, C. hyo-
intestinalis, C. jejuni, C. lari, C. upsaliensis, Clostridium 
botulinum,  Cl. perfringens,  Escherichia albertii,  E. 
coli,  E. fergusonii,  Salmonella enterica,  Shigella boy-
dii,  S. dysenteriae,  S. flexneri,  S. sonnei,  Vibrio para-
haemolyticus  and  Yersinia enterocolitica  [24]. Hits to 
the reference genome with at least 70% nt identity 
were kept and used to determine the proportion of 
the query genome covered by the reference genome. 
Mean and standard deviations (SD) of these propor-
tions per reference genome were determined after one 
round of removing outliers with z-scores higher than 3 
for the same genus and z > 6 for different genus refer-
ences. Assemblies that were longer than 3.3 Mb were 
considered to be contaminated with another species as 
well. The contamination (CNTM) QC was set to WARN 
when a species of another genus was detected and to 
FAIL when other  Listeria  species were detected, since 
in the latter case it is likely that this will substantially 
interfere with allele calling.
Checks for  Lm  mixed cultures are much more difficult 
to assess than contamination with other species due 
to the inherent similarity between the strains. The QC 
used here was based on the multiple allele call results 
of cgMLST allele calling on SPAdes assembled genomes 
(see allele calling section). The number of core genome 
loci with multiple alleles (CGM) was used as an indi-
cator that sequences are likely to originate from con-
taminated cultures. The CGM QC was set to WARN for 
isolates with CGM = 1, i.e. one locus with multiple allele 
calls, and to FAIL if CGM > 1.
Checks for sequence read quality were done based on 
the core genome coverage (CGC). This was defined as 
the proportion of core genome loci that were retrieved 
through allele calling. For each such locus, a biologi-
cally meaningful allele can therefore be found, includ-
ing a start and a stop codon and a minimum similarity 
to curated reference alleles. Since DNA or sequencing 
quality issues are not expected to be biased towards 
core or accessory genome, the CGC values can be 
expected to be representative of the quality of the 
whole genome.
Rarefaction analysis
Rarefaction curves were estimated for the effect of 
decreasing sampling fraction on both proportion of 
clustering vs sporadic isolates. This was also done to 
estimate the effect of decreasing CGC on allelic dis-
tances between closely related isolates, in order to 
Table 3
Single- and multi-country clusters, Listeria monocytogenes whole genome sequencing study, European Union/European 
Economic Area, 2010‒2015
Cluster size 
(n) Total (n)
Single country Multi-country
N %
Each country one 
isolate
Some countries with more 
than one isolate Average time gained through 
detection at EU-level (days)
N % N %
Cutoff (AD)  ≤ 4 (n = 317)
2 172 132 76.7 40 23.3 NA NA NA
3–5 98 60 61.2 4 4.1 34 34.7 144
> 5 47 25 53.2 0 0.0 22 46.8 75
Cutoff (AD)  ≤ 7 (n = 331)
2 166 125 75.3 41 24.7 NA NA NA
3–5 109 68 62.4 4 3.7 37 33.9 136
> 5 56 25 44.6 0 0.0 31 55.4 154
AD: allelic distance; EU: European Union; NA: not applicable.
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assess to what extent CGC affects cgMLST analysis and 
cluster detection. The allelic distance (AD) between a 
pair of isolates was defined as the number of alleles 
across all loci in the scheme that are different, ignoring 
loci not present in either or both isolates. Estimations 
for all curves were performed with at least 100 random 
samples per point.
Results
Dataset
Table 1 presents the sequenced isolates by country and 
the respective proportion of officially reported listeri-
osis cases by year, retrieved from the European Centre 
for Disease Prevention and Control (ECDC) Surveillance 
Atlas of Infectious Diseases [4]. Overall in EU/EEA 
countries, 20–28% of all isolates from reported cases 
were sequenced for each year. This is a relatively uni-
form representativeness, though there was substantial 
variation between individual countries and also for 
some countries over the years.
Sequence data quality
The contamination (CNTM) QC detected three  L. 
ivanovii  isolates (0.1%; CNTM result set to FAIL) and 
31 isolates that contained bacterial DNA from genera 
other than Listeria spp. (1.1%; CNTM set to WARN). The 
mixed Lm culture (CGM) QC detected two isolates with 
CGM =  1 (WARN) and six with CGM >  1 (ranging 2–21; 
FAIL). Of these eight isolates, five also had CNTM 
WARN, due to assembly lengths > 3.3 Mb.
The final quality issue that was investigated was 
poor quality of the sequence reads using the CGC QC. 
Rarefaction analysis of artificially reduced CGC by ran-
domly deleting loci was performed using Moura CG, 
SPAdes assembly and including only isolates with actual 
CGC ≥  95%, CNTM PASS and CGM PASS (n = 2,664). 
This showed that a reduction from 99.5% on average 
to 95.0%, 90.0% and 80.0% led to an increase in the 
number of isolate pairs with AD ≤ 7 by 9.9%, 26.1% and 
89.5%, respectively (Figure 1a). Based on this, and the 
fact that most of these additional pairs remained in the 
AD 5–7 region, we selected PASS ≥ 95% and FAIL < 90% 
(WARN between 90–95%) as thresholds for this QC. 
A total of 2,692 (98.8%) isolates passed, 16 (0.6%) 
passed with a warning and 18 (0.7%) failed.
 
Figure 1b shows the impact of the average coverage on 
the CGC QC, with a clear improvement in the proportion 
of acceptable isolates as coverage increases up to 
around 55x before trimming and 45x after trimming. 
Only CNTM PASS and CGM PASS isolates were included 
and 83 IonTorrent sequences (3.0%) were excluded 
from this analysis in order to not mix results from two 
different platforms, leaving n  =  2,609 isolates for the 
analysis. In contrast, the corresponding curve for a 
stricter threshold of 97.5% for acceptable CGC reaches 
this plateau only at around 80x coverage before trim-
ming (data not shown).
In summary, for our dataset, 22 isolates (0.8%) failed 
at least one QC and were classified as ‘Rejected’. 
No association was found between the sequencing 
platform used and failing the CGC QC that assesses 
sequence quality. A total of 40 isolates (1.5%) passed 
at least one QC with a warning but failed none, and 
these were classified as ‘AcceptedForOutbreak’. The 
remaining 2,664 (97.7%) passed all three QCs and were 
classified as ‘Accepted’, and only these were used for 
subsequent analyses on analytical and epidemiologi-
cal validation.
Analytical validation
The variation introduced by using different input data 
(directly reads, SPAdes assemblies or Velvet assem-
blies) and different schemes (Moura CG or Ruppitsch 
CG) is summarised in  Table 2, based primarily on the 
difference in AD (ΔAD), between the most relevant pairs 
of methods. Other pairs gave near-identical results 
(data not shown). The ΔADbetween SPAdes and Velvet 
was small, with a mean of -0.19 vs -0.29 depending on 
the scheme for AD ≤  7. Velvet had in 4,477 of 50,083 
(8.9%) pairs at least one additional allelic difference 
compared with SPAdes among loci present in both 
assemblies for the AD ≤ 150 set, with 83 (0.2%) for the 
reverse case. The Velvet assembly length was also 
shorter in 667 of 1,023 (65.2%) cases where a Velvet 
assembly was performed. Further assembly-based 
analyses were therefore based on SPAdes, though 
results were near-equivalent. The ΔAD between SPAdes-
based and reads-based allele calling was slightly 
skewed towards more differences based on reads, 
even though less loci were detected from the reads. 
Reads-based allele calling therefore seems prone to 
more variation than assembly-based allele calling. The 
difference between the two core genome schemes was 
larger than that between reads and assembly-based 
allele calling.
Epidemiological validation
Our dataset contained 19 confirmed outbreaks from 10 
EU/EEA countries with a median of 6.5 cases (range: 
3–19), plus two mother-child pairs, encompassing 152 
isolates. These outbreaks were both microbiologi-
cally and epidemiologically confirmed by the respec-
tive national authorities, but confirmation was done 
using microbiological typing methods other than WGS. 
The outbreaks therefore represent an independent 
test set for evaluating epidemiological concordance 
of WGS. The number of corresponding epidemiologi-
cally linked pairs decreased with increasing AD (Figure 
2a), confirming that low cgMLST AD strongly correlates 
with epidemiological linkage. This pattern was similar 
between the two cgMLST schemes, as well as between 
allele calling approaches (data not shown). 
Cluster detection was done using single linkage clus-
tering and subsequently applying a cluster cutoff to 
the tree. For each of the confirmed outbreaks, only the 
cluster that had the most isolates in common with the 
outbreak was considered to be the predicted outbreak. 
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Based on this, true positive, false positive and false 
negative isolates were enumerated and summed across 
the outbreaks.  Figure 2b  shows both the resulting 
positive predictive value (PPV) and the sensitivity as a 
function of the cluster cutoff. As for isolate pairs, both 
cgMLST schemes have similar performance and, in both 
cases, sensitivity reaches a plateau of > 95% at AD ≤ 4. 
PPV was 65.3% vs 67.6% for Moura CG vs Ruppitsch CG 
at AD ≤  4 and 58.2% vs 66.7% at AD ≤  7. There were, 
for example, 28 vs 33 (Moura CG vs Ruppitsch CG) iso-
lates matching with AD =  0 to one of the 152 isolates in 
confirmed outbreaks, indicating that the real PPV and 
sensitivity may still be higher since all of these isolates 
would also have been classified as true positives.
Microbiological cluster detection
The proportion of sporadic cases, i.e. cases that do not 
cluster with any other, was 47.0% vs 47.8% using AD ≤ 7 
and 54.5% vs 55.2% using AD  ≤ 4.  Figure 2c  shows 
the effect of sampling fraction on the proportion of 
sporadic cases, using rarefaction and the Moura CG 
(similar results for Ruppitsch CG, data not shown). 
The isolates that clustered were further stratified by 
belonging to either a single- or a multi-country cluster.
Table 3 further stratifies the number of clusters based 
on size, cluster cutoff and single- vs multi-country. 
Among the multi-country clusters, a distinction is made 
between clusters in which each country has only one 
isolate, and that can thus only be detected at EU/EEA 
level, and clusters in which at least one country has 
more than one isolate. The latter can be detected first 
either at national level or at EU/EEA level, depending 
on whether the second isolate of any involved country 
is also the second isolate overall. The average number 
of days that EU/EEA level detection for clusters of more 
than five isolates was earlier than national detection 
was at least 75 (AD ≤ 4) and at most 154 (AD ≤ 7). This 
indicates that, in terms of timeliness of detection, 
there can be a substantial gain by pooling data at the 
EU/EEA level.
Finally, the 6-year time span of this dataset also 
allows examination of the evolution of clusters over 
time.  Figure 2d shows the aggregated number of iso-
lates over a period of nearly 4 years belonging to the 
same cluster, with the first isolate in the cluster set at 
t = 0. These clusters were created using single linkage 
clustering and different AD cutoffs of 0, ≤ 4 and ≤ 7 to 
assess the impact of the cutoff on cluster duration and 
size. For our dataset, and using cutoff AD ≤ 7, clusters 
of sizes two, three and larger than three had a median 
duration of 16, 78 and 112 weeks, respectively, for 
single-country clusters. For multi-country clusters, this 
increased to 34, 84 and 181 weeks, respectively.
Discussion
In this large multi-country study, we examined both 
the analytical and general epidemiological aspects of 
surveillance for human  Lm  infections using WGS. We 
identified CGC as the one main quality indicator that 
detected most of the quality issues in WGS data. CGM 
and contamination checks were also investigated, but 
these identified few additional issues, although further 
research on the extent and impact of contaminations 
and mixed cultures is warranted. The low occurrence 
of contamination indicates a high level of quality 
among participating laboratories. Quality control crite-
ria were established to classify isolates as ‘Accepted’, 
‘AcceptedForOutbreak’ and ‘Rejected’.
We conclude that the isolate sequences classified as 
‘Accepted’ by the criteria outlined here are of suffi-
cient quality to be a reliable basis for supporting epi-
demiological investigations and, in particular, cluster 
detection and outbreak investigations, also in an inter-
national setting. Although 2.3% of the isolates did not 
reach this level of quality, there is a clear correlation 
with the average coverage up to around 55x before 
trimming and 45x after trimming for the Illumina plat-
form. This would therefore be a recommended mini-
mum coverage for this platform for laboratories getting 
started with WGS for  Lm  to ensure the reliability of 
the data and downstream analyses, consistent with 
previous reports [10]. It is also possible that further 
improvements through, for example, internal and exter-
nal quality assessment exercises and new sequencing 
technology, could result in lower coverage yielding the 
same quality.
Based on the comparison of different allele calling 
methods, it can be concluded that assembly-based 
allele calling outperforms reads-based allele calling 
with the methods used here. More loci were detected, 
which increased typeability, and the average distances 
between isolates were slightly smaller. Velvet includ-
ing k-mer optimisation performed slightly worse than 
SPAdes, but both produced near-equivalent results. 
This provides an important opportunity to simplify 
the cooperation between national public health insti-
tutes and laboratories on WGS-enhanced surveillance, 
thereby enhancing their ability to respond to listeriosis 
cross-border clusters and outbreaks. Provided that val-
idated assemblers are used to assure data reproduc-
ibility [10], and in the absence of a globally accepted 
unique strain nomenclature to classify isolates, it is 
sufficient for cgMLST analysis to share assembled 
genomes rather than sequence read data, which often 
require an additional separate system and workload. 
When further confirmation is required, e.g. when decid-
ing on control measures in multi-country outbreaks, it 
may still be necessary to share sequence reads, e.g. for 
SNP analysis or to verify the analyses, but this is likely 
only for a small minority of the cases. For communica-
tion on outbreaks or detected clusters, it is important 
to keep in mind that the individual differences in ADs 
between Moura and Ruppitsch CG schemes can be 
relatively large, due to the different set of loci used, 
since only 1,261 loci are common to both schemes 
[10]. This may impact the formulation of outbreak case 
definitions, which should always specify what cgMLST 
scheme(s) are used, as well as their total number of 
loci, minimum WGS quality criteria and cutoffs.
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The AD ≤  7 cutoff defined in Moura et al. is confirmed 
as useful for cluster detection for both the Moura and 
the Ruppitsch CG [10,23]. A more stringent cluster cut-
off of AD ≤  4 in combination with single linkage clus-
tering may be considered for identifying isolates with 
more compelling microbiological evidence of being 
part of the same outbreak. A second higher cutoff 
for weaker microbiological evidence could be applied 
as well, in order to define, for example, confirmed vs 
probable cases in an outbreak case definition. More 
confirmed outbreaks are needed to have a more accu-
rate estimation of PPV and sensitivity as a function of 
cluster cutoff. Since confirmed outbreaks were deline-
ated at national level only and using less discrimina-
tory methods than cgMLST, there may be additional 
isolates in the dataset that are actually part of one of 
the confirmed outbreaks, leading to underestimation 
of PPV and possibly sensitivity. More confirmed out-
breaks are also needed to understand why epidemio-
logically linked isolates could have substantially more 
allele differences than the cutoff, as described earlier 
[9,10]. One possibility for microbiological diversity in 
an epidemiological cluster is that a single source or 
environmental niche may be occupied by more than 
one strain. Another is that specific sublineages may 
have higher average mutation rates, and if sufficient 
evidence is available to justify it, sublineage-specific 
cutoffs could be defined. Reliability of establishing 
microbiological relatedness is crucial in practice for 
public health, since it increases the power of analytical 
studies on exposure data. In addition, though unlikely 
for Lm given its low incidence and high severity, when 
exposure data cannot be gathered for all cases, it 
would help in selecting the cases for which to gather 
exposure data.
The aggregated curves of number of cases as a func-
tion of time were also similar regardless of the cutoff 
used (Figure 1d), indicating that clusters of closely 
related isolates can persist for several years, as pre-
viously reported [11,26-28]. Such a long time span of 
microbiological clusters can be expected given the 
microbiological properties of Lm, such as a slow muta-
tion rate of around 1 SNP per year and the ability to form 
biofilms that are difficult to eradicate in food process-
ing environments [6,7,10,29]. This is important to take 
into account, especially for control measures, since 
knowledge of retrospective isolates, whether from 
human cases or food sources, may still inform inves-
tigations of new cases [9,11,27,30]. Therefore, an addi-
tional restriction on time for defining microbiological 
clusters of Lm does not seem warranted for descriptive 
epidemiology and hypothesis generation, while it 
is likely still required for analytical epidemiological 
studies.
Around a third of the clusters found involved more 
than one country, and for clusters of more than five 
isolates this increased to around half. This can be 
expected given the international nature of food trade, 
and indicates that there is potential for a substantial 
added public health value of introducing EU/EEA-wide, 
WGS-enhanced surveillance of listeriosis. Among other 
benefits, it may lead to earlier detection of clusters, 
which in our dataset was on average several months 
for multi-country clusters. At the same time, the molec-
ular typing results must also be combined with epide-
miological and food exposure investigations. Given the 
sometimes-long incubation period of listeriosis, the 
low number of cases and the severity of the disease, 
food exposure data should ideally be collected for all 
cases, without additional waiting for typing results, as 
presently done in, for example, Denmark, France and 
the US. It should also be complemented by WGS typing 
of officially sampled food isolates, and be combined 
with a joint analysis of the microbiological data to 
detect potential links between human cases and food 
items [11,31]. The successful implementation of control 
measures for multi-country persistent clusters also 
requires cross-border investigations and intense col-
laboration of public health and food safety authorities 
and laboratories.
Assuming that all isolates clustering within the cutoff 
are epidemiologically linked, there is a substantial 
amount of apparently sporadic cases [32]. Based on 
the rarefaction analysis, around half of the cases in this 
study were sporadic cases. However, this proportion 
is likely to be slightly lower for comprehensive sam-
pling. Any bias in the selection of isolates in the differ-
ent countries, with respect to their likelihood of being 
part of an outbreak, may also affect this number. It is 
likely that some proportion of cases is truly sporadic 
in the sense that they are isolated cases related to 
individual- or household-level food preparation or stor-
age practices, rather than to the microbiological qual-
ity of the food at the time of purchase [33]. In general, 
these cases can only be addressed through preventive 
measures such as public education, rather than control 
measures for food business operators. Further research 
is needed to determine to what extent specific popula-
tions face an increased risk, as well as how preventive 
measures such as microbiological criteria for food could 
be improved. Finally, similar studies could be useful 
for other pathogens, in particular  Salmonella enter-
ica,  Shiga toxin-/verocytotoxin-producing  Escherichia 
coli  (STEC/VTEC) and  Campylobacterspp., to establish 
appropriate sequence quality criteria, to assess epide-
miological concordance as a function of the analysis 
method and to estimate the added value of national 
and EU/EEA-wide WGS-enhanced surveillance.
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